Background The selective co-stimulation modulator abatacept demonstrated efficacy for treating rheumatoid arthritis in early clinical studies.Objective To evaluate the effects of abatacept in patients with persistent, active rheumatoid arthritis despite methotrexate treatment.Design One-year, multic...
No comments yet
Be the first to share your thoughts!